March 09, 2026
Foley Hoag is pleased to announce that Marc Graboyes, counsel in the firm’s Denver office, has been appointed to the Colorado BioScience Association (CBSA) Board of Directors. CBSA announced its new board leadership and incoming members as part of its ongoing commitment to advancing Colorado’s life sciences ecosystem.
Mr. Graboyes is a corporate attorney who represents emerging companies and investors in the life sciences and technology sectors. His practice focuses on general corporate matters, including corporate governance, venture financings, mergers and acquisitions, and commercial transactions. He joins a board composed of accomplished life sciences entrepreneurs, executives, researchers, and industry leaders who will help shape the future of Colorado’s thriving health innovation community.
“CBSA plays a pivotal role in advancing our state’s life sciences community, and I’m thrilled to support that work as a member of the Board of Directors,” said Graboyes. “Foley Hoag’s expansion in the Denver market reflects the remarkable innovation happening across Colorado, and I’m excited to help our region’s entrepreneurs, researchers, and investors continue shaping the future of this dynamic ecosystem.”
CBSA’s Board plays a central role in guiding strategic planning, shaping public policy priorities, strengthening access to capital, and supporting the growth of companies across all stages of commercialization. Colorado’s life sciences community employs nearly 41,000 people and generates more than $50 billion in economic impact statewide.
